Back to search
Primary Membranous Nephropathy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Membranous Nephropathy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Membranous Nephropathy trials you may qualify forThe purpose of this study is to assess the safety, tolerability, pharmacokinetic, and efficacy of surovatamig administered by subcutaneous injection in adult pa…
In this study, researchers will learn more about the use of felzartamab in participants with primary membranous nephropathy, also known as PMN. In people with P…
To evaluate the efficacy and safety of B007 in the Treatment of Primary Membranous Nephropathy
This Phase I Clinical Study assessed the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles and Preliminary Efficacy of Subcutaneous Injection o…
To evaluate the safety and tolerability of three dose regimens of budoprutug in subjects with PMN
The purpose of this study is to evaluate the efficacy, safety, and tolerability of povetacicept in participants with primary membranous nephropathy (pMN).
This study will evaluate the efficacy, safety, pharmacodynamics, and pharmacokinetics (PK) of obinutuzumab compared with tacrolimus in participants with primary…
This is a non-pharmacological interventional monocentric study to primarily assess the levels of circulating phospholipase A2 receptor (PLA2R)-specific B cells…